Cancer researcher with 15 years of experience in biomarker discovery and development of novel targeted therapies for hematologic and solid tumors. My work encompasses important contributions to cancer biology and antitumor drug development, with a focus on elucidating the mechanisms of action and resistance to therapies currently advancing in clinical trials. I have identified biomarkers for monitoring therapeutic activity and diagnosing aggressive cancer subtypes.
Currently, I am a Scientific Research Lead at Memorial Sloan Kettering Cancer Center, where my portfolio includes the discovery of molecular cancer drivers in diverse populations and the development and clinical validation of novel assays and technologies, using noninvasive approaches such as liquid biopsies, for early cancer detection and prediction of treatment response. Throughout my career, I have guided the professional growth of more than 10 scientists at various stages of their careers.
Cancer researcher with 15 years of experience in biomarker discovery and development of novel targeted therapies for hematologic and solid tumors. My work encompasses important contributions to cancer biology and antitumor drug development, with a focus on elucidating the mechanisms of action and resistance to therapies currently advancing in clinical trials. I have identified biomarkers for monitoring therapeutic activity and diagnosing aggressive cancer subtypes.
Currently, I am a Scientific Research Lead at Memorial Sloan Kettering Cancer Center, where my portfolio includes the discovery of molecular cancer drivers in diverse populations and the development and clinical validation of novel assays and technologies, using noninvasive approaches such as liquid biopsies, for early cancer detection and prediction of treatment response. Throughout my career, I have guided the professional growth of more than 10 scientists at various stages of their careers.